Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionPacer Advisors, Inc.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Pacer Advisors, Inc. closes position in CORT / Corcept Therapeutics Incorporated

On May 6, 2026 - Pacer Advisors, Inc. filed a 13F-HR form disclosing ownership of 0 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 24, 2026 disclosing 2,030 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Corcept Therapeutics Common Stock - Domestic 218352102 0 -2,030 -100.00 0 -100.00
2026-02-24 2025-12-31 13F/A-1 Corcept Therapeutics Common Stock - Domestic 218352102 2,030 -388,529 -99.48 71 -99.78 0.0002
2025-10-15 2025-09-30 13F Corcept Therapeutics Common Stock - Domestic 218352102 390,559 384,896 6,796.68 32,459 7,721.45 0.0817
2025-08-12 2025-06-30 13F Corcept Therapeutics Common Stock - Domestic 218352102 5,663 -5,237 -48.05 416 -66.64 0.0010
2025-05-06 2025-03-31 13F Corcept Therapeutics Common Stock - Domestic 218352102 10,900 4 0.04 1,245 126.59 0.0029
2025-01-22 2024-12-31 13F Corcept Therapeutics Common Stock - Domestic 218352102 10,896 1,689 18.34 549 28.87 0.0012
2024-11-12 2024-09-30 13F Corcept Therapeutics Common Stock - Domestic 218352102 9,207 5,355 139.02 426 240.80 0.0009
2024-08-13 2024-06-30 13F Corcept Therapeutics Common Stock - Domestic 218352102 3,852 2,728 242.70 125 346.43 0.0003
2024-05-10 2024-03-31 13F Corcept Therapeutics Common Stock - Domestic 218352102 1,124 -173 -13.34 28 -33.33 0.0001
2024-01-16 2023-12-31 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 1,297 -118 -8.34 42 10.53 0.0001
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 1,415 754 114.07 39 171.43 0.0001
2023-07-12 2023-06-30 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 661 -518,895 -99.87 15 -99.88 0.0001
2023-05-02 2023-03-31 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 519,556 61,087 13.32 11,254 20.86 0.0481
2023-02-06 2022-12-31 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 458,469 148,864 48.08 9,312 17.30 0.0476
2022-10-18 2022-09-30 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 309,605 -53,698 -14.78 7,938 -8.11 0.0553
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 363,303 102,693 39.40 8,639 47.20 0.0642
2022-04-05 2022-03-31 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 260,610 11,350 4.55 5,869 18.93 0.0481
2022-02-03 2021-12-31 13F CORCEPT THERAPEUTICS Common Stock - Domestic 218352102 249,260 249,260 4,935 0.0506
2021-01-20 2020-12-31 13F CORCEPT THERAPEUTICS Common Stock 218352102 0 -18,327 -100.00 0 -100.00
2020-10-19 2020-09-30 13F CORCEPT THERAPEUTICS Common Stock 218352102 18,327 2,202 13.66 319 17.71 0.0068
2020-07-29 2020-06-30 13F CORCEPT THERAPEUTICS Common Stock 218352102 16,125 1,058 7.02 271 42.63 0.0055
2020-04-23 2020-03-31 13F CORCEPT THERAPEUTICS Common Stock 218352102 15,067 -14,709 -49.40 190 -47.22 0.0038
2020-02-10 2019-12-31 13F CORCEPT THERAPEUTICS Common Stock 218352102 29,776 -5,493 -15.57 360 -27.86 0.0163
2019-10-10 2019-09-30 13F CORCEPT THERAPEUTICS Common Stock 218352102 35,269 -3,368 -8.72 499 15.78 0.0112
2019-08-12 2019-06-30 13F CORCEPT THERAPEUTICS Common Stock 218352102 38,637 -986 -2.49 431 -7.31 0.0105
2019-04-10 2019-03-31 13F CORCEPT THERAPEUTICS Common Stock 218352102 39,623 15,238 62.49 465 42.64 0.0129
2019-02-13 2018-12-31 13F CORCEPT THERAPEUTICS Common Stock 218352102 24,385 10,666 77.75 326 69.79 0.0115
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS Common Stock 218352102 13,719 13,719 192 0.0072
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.